
Opinion|Videos|September 20, 2024
Role of Biosimilars in Gastrointestinal Diseases
Author(s)Jennifer Seminerio, MD
A gastroenterologist discusses the role of biosimilars in her clinical practice.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How have the introduction of IV biosimilars impacted your treatment decisions? Do you see subQ biosimilars having a role in the future?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5

























